Patent · US Active

Compounds

US10098881B2 · kind B2 · utility

5Cited by
11References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 11, 2017
Grant dateOct 16, 2018
Priority date—
Expiry dateOct 11, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods for the treatment of Fragile X that includes administering to a subject in need thereof a compound of formula (I): are described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.